Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving epratuzumab and rituximab together may be more effective in treating follicular non-Hodgkin lymphoma. PURPOSE: This phase II trial is studying how well giving epratuzumab together with rituximab works in treating patients with previously untreated follicular non-Hodgkin lymphoma.
Key facts
- Study ID
- NCT00553501
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 60
- Starts
- 2008-03-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2016-07-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Medical Office -Vandever Medical Office — San Diego, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Middlesex Hospital Cancer Center — Middletown, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center — Lewes, Delaware, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- University of Illinois Cancer Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Elkhart General Hospital — Elkhart, Indiana, United States
- Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana, United States
- Howard Community Hospital — Kokomo, Indiana, United States
- Center for Cancer Therapy at LaPorte Hospital and Health Services — La Porte, Indiana, United States
- CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
- Cancer Institute of New Jersey at Cooper - Voorhees — Voorhees Township, New Jersey, United States
- CCOP - Hematology-Oncology Associates of Central New York — East Syracuse, New York, United States
- New York Weill Cornell Cancer Center at Cornell University — New York, New York, United States
- Wayne Memorial Hospital, Incorporated — Goldsboro, North Carolina, United States
- Kinston Medical Specialists — Kinston, North Carolina, United States
- Iredell Memorial Hospital — Statesville, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center — Columbus, Ohio, United States
- Mountainview Medical — Berlin Corners, Vermont, United States
- Fletcher Allen Health Care - University Health Center Campus — Burlington, Vermont, United States
- Danville Regional Medical Center — Danville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.